BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 34686717)

  • 1. Effects of BRD4 inhibitor JQ1 on the expression profile of super-enhancer related lncRNAs and mRNAs in cervical cancer HeLa cells.
    Zheng J; Huang B; Xiao L; Wu M
    PeerJ; 2024; 12():e17035. PubMed ID: 38410799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Omics Mining of lncRNAs with Biological and Clinical Relevance in Cancer.
    Salido-Guadarrama I; Romero-Cordoba SL; Rueda-Zarazua B
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncmiRHG-MIR100HG: A new budding star in cancer.
    Wu Y; Wang Z; Yu S; Liu D; Sun L
    Front Oncol; 2022; 12():997532. PubMed ID: 36212400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining new biomarkers for overcoming therapeutical resistance in cervical cancer using lncRNA.
    Aswathy R; Sumathi S
    Mol Biol Rep; 2023 Dec; 50(12):10445-10460. PubMed ID: 37878205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives.
    Ranga S; Yadav R; Chhabra R; Chauhan MB; Tanwar M; Yadav C; Kadian L; Ahuja P
    Apoptosis; 2023 Aug; 28(7-8):925-942. PubMed ID: 37095313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic identification of genomic instability-associated lncRNAs signatures for improving the clinical outcome of cervical cancer by a prognostic model.
    Zhang J; Ding N; He Y; Tao C; Liang Z; Xin W; Zhang Q; Wang F
    Sci Rep; 2021 Oct; 11(1):20929. PubMed ID: 34686717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma.
    Huang DP; Liao MM; Tong JJ; Yuan WQ; Peng DT; Lai JP; Zeng YH; Qiu YJ; Tong GD
    Aging (Albany NY); 2021 Nov; 13(22):24621-24639. PubMed ID: 34799469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
    Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
    Front Immunol; 2022; 13():929846. PubMed ID: 35990656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis.
    Liang Y; Sun HX; Ma B; Meng QK
    Dis Markers; 2022; 2022():4556585. PubMed ID: 35711569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
    Wu H; Zhang ZY; Zhang Z; Xiao XY; Gao SL; Lu C; Zuo L; Zhang LF
    Bioengineered; 2021 Dec; 12(1):1725-1738. PubMed ID: 33955803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative transcriptome profiling of horseshoe crab Tachypleus gigas hemocytes in response to lipopolysaccharides.
    Sarmiento ME; Chin KL; Lau NS; Aziah I; Ismail N; Norazmi MN; Acosta A; Yaacob NS
    Fish Shellfish Immunol; 2021 Oct; 117():148-156. PubMed ID: 34358702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability.
    Tayoun T; Oulhen M; Aberlenc A; Farace F; Pawlikowska P
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding How Genetic Mutations Collaborate with Genomic Instability in Cancer.
    Jilderda LJ; Zhou L; Foijer F
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
    Shimomura M; Fukuda T; Awazu Y; Nanno S; Inoue Y; Matsubara H; Yamauchi M; Yasui T; Sumi T
    Oncol Lett; 2021 Feb; 21(2):150. PubMed ID: 33552268
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.